insights_auto
Why is SABS down 9,06%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
2,91 US$
arrow_downward
-9,06%(-0,29) 1D
2,96 US$
arrow_upward
+1,80% (+0,052)bedtimeAfter hours
Closed: 19 ნოე, 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
3,20 US$
High
3,21 US$
Low
2,54 US$
Mkt. cap
262,16 მლნ.
Avg. vol.
689,33 ათ.
Volume
1,75 მლნ.
52-wk high
5,15 US$
52-wk low
2,44 US$
EPS
-0,93 US$
Beta
0,67
Shares outstanding
90,09 მლნ.
No. of employees
86
Open
3,20 US$
High
3,21 US$
Low
2,54 US$
Mkt. cap
262,16 მლნ.
Avg. vol.
689,33 ათ.
Volume
1,75 მლნ.
52-wk high
5,15 US$
52-wk low
2,44 US$
EPS
-0,93 US$
Beta
0,67
Shares outstanding
90,09 მლნ.
No. of employees
86
News stories
From web sources and news partners
Investing.com
·
2 დღის წინ
SAB Biotherapeutics at UBS conference: late-stage diabetes bet
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
Headquartersმაიამი-ბიჩი, ფლორიდა, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websitesab.bio